Overview the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets Status: Recruiting Trial end date: 2021-10-01 Target enrollment: Participant gender: Summary Multiple Dose Safety, Tolerability, PK ，PD and Food Effect Study of HEC83518 in Healthy Subjects Phase: Phase 1 Details Lead Sponsor: Sunshine Lake Pharma Co., Ltd.